Bellerophon Therapeutics Inc (BLPH): mallinkrodt sees potential for nitrous o...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	797
Boards Moderated	0
Alias Born	08/10/2011

jdlamont

Re: None

Monday, 04/06/2020 4:48:03 PM

Monday, April 06, 2020 4:48:03 PM

mallinkrodt sees potential for nitrous oxide for cover treatment, clears fad to start own trial.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent BLPH News

Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 02:29:00 PM
Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 07:31:31 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 03:46:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:21:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:20 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/03/2024 06:49:05 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/27/2023 02:50:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 12:51:41 AM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 10/16/2023 05:59:54 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/16/2023 05:59:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 02:30:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 12:45:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:05:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:10:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 08:06:11 PM

More BLPH News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover